C-Path’s Nonprofit Partners
Critical Path Institute is proud to partner with nonprofits across the globe to accelerate the development of therapies for people with unmet medical needs. We are grateful to our nonprofit partners and global collaborators who walk alongside us in this journey. Together with the partners listed below, we’re not just imagining a better, healthier world—we’re building it.
- CHI
- The Cystic Fibrosis Therapeutics Development Network
- The Epilepsy Foundation
- FamilieSCN2A Foundation
- Foundation for Angelman Syndrome Therapeutics Australia
- Friedreich’s Ataxia Research Alliance (FARA)
- Hereditary Neuropathy Foundation
- The International Pemphigus & Pemphigoid Foundation
- MitoAction
- NORD
- Parent Project Muscular Dystrophy
- Rare Epilepsy Network
- The Desmoid Tumor Research Foundation (DTRF)
- Sturge-Weber Foundation
- TSC Alliance
- The Association for Frontotemporal Degeneration
- CurePSP
- Novartis
- Rainwater Charitable Foundation
- Barth Syndrome Foundation
- The Champ Foundation
- CortexBio
- CureARS
- Sumptuous Data Sciences
- Cure Mito Foundation
- Hope for PDCD Foundation
- Leber Hereditary Optic Neuropathy Collective
- Quest Diagnostics
- MitoAction
- MitoCanada
- MitoWorld
- The Translational Genomics Research Institute (TGen)
- Undiagnosed Diseases Network (UDN)
- Cure LBSL
- Sanford Health
